Infectious Disease Advisor news stories
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Real-world data support BIC/FTC/TAF switch in adults with HIV
Switching to bictegravir plus emtricitabine and tenofovir alafenamide (BIC/FTC/TAF) represents a safe and effective regimen-optimization strategy among individuals with HIV who are virologically suppressed on antiretroviral therapy, according to study findings published in Infectious Diseases and Therapy.
Long-acting ART achieves HIV virologic suppression in patients with viremia
Real-world data support long-acting antiretroviral therapy (ART) for people with HIV, including among those who are viremic at initiation, according to study findings published in Clinical Infectious Diseases.
Related HIV and Co-Infections News
-
Contagion Live: Redefining HIV management: Emerging antiretroviral drug classes and immunologic strategies shaping the future of HIV treatment, prevention
-
[AIDS 2026] aidsmap: Returning to HIV care does not erase the effects of treatment interruption, studies show
-
HIV i-Base: AIDS 2026: New HIV drugs in the ART pipeline
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.